Table 2. . Immunostaining scores and correlation of p16 and p53 in ADCs and SQCCs.
| Markers | IHC score | Positive rate | |||
|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | ||
| p16 | |||||
| ADC (n = 75) | 37 (49.3%) | 23 (30.7%) | 12 (16.0%) | 3 (4.0%) | 50.7% |
| SQCC (n = 88) | 57 (64.8%) | 11 (12.5%) | 8 (9.1%) | 12 (13.6%) | 35.2% |
| p53 | |||||
| ADC (n = 75) | 32 (42.7%) | 20 (26.7%) | 9 (12.0%) | 14 (18.6%) | 57.3% |
| SQCC (n = 88) | 32 (36.4%) | 10 (11.4%) | 24 (27.2%) | 22 (25.0%) | 63.6% |
ADC: Adenocarcinoma; IHC: Immunohistochemistry; SQCC: Squamous cell carcinoma.